Natco Pharma Completes Transition of DASH Pharmaceuticals into Natco Pharma
Enforcement Report - Week of April 13, 2022
Natco Pharma Limited through its affiliates is proposing to enter into an agreement to acquire Dash Pharmaceuticals LLC subject to satisfactory completion of due diligence, execution of definitive agreements and compliance with statutory requirements.